Marks & Clerk UK promotes two to partnership
UK IP firm Marks & Clerk LLP has announced two of its attorneys will be joining the firm’s partnership.
Austria becomes first country to ratify Unified Patent Court agreement
Austria has become the first country in the EU to ratify consent to the Unified Patent Court.
Miles & Stockbridge welcomes eight IP professionals
US law firm Miles & Stockbridge PC has continued the expansion of its IP practice with the addition of seven lawyers and one patent agent.
Eli Lilly bids to stop generics cutting Alimta exclusivity
Eli Lilly has begun its defence of a patent covering lung cancer drug Alimta against generic companies including Teva, Barr Laboratories and APP Pharmaceuticals.
Horizon Pharma settles Duexis case with Par Pharmaceuticals
US-based Horizon Pharma Inc agreed on August 22 to settle its patent dispute over arthritis drug Duexis with generic maker Par Pharmaceutical Companies.
Roche relinquishes patent on breast cancer drug
Drugmaker Roche has decided not to pursue a patent application for a breast cancer drug in the Indian market, enabling rivals to possibly produce cheaper versions.
Allergan sued over breast implant patent
Texas-based Almha has launched patent infringement lawsuits against four companies, including UK company Allergan, in relation to its patent covering a “breast implant with position lock”.
Sheppard Mullin hires partner in California
Lorna Tanner has joined the Palo Alto office of Sheppard Mullin Richter & Hampton LLP as an IP partner.
SIPO pulls Viread patent – victory for pharma innovators?
The Chinese State Intellectual Property Office (SIPO) has revoked a patent covering biopharmaceutical company Gilead Science’s HIV drug Viread, Reuters subsidiary news site BioWorld reported.
IPAB revokes Allergan eye drug patent
On August 8 the IPAB revoked another patent owned by a Western pharmaceutical company – this time related to Allergan’s eye drug Combigan.
